Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aurora Biosciences (ABSC) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Haugland who wrote (132)	7/16/1998 9:52:00 PM
From: Machaon	Respond to of 359

From the article: << The agreement also anticipates the use of Aurora's Ultra-high Throughput Screening System ("UHTSS") which is planned to come on line in 1999. >> Once more, a press release is issued, reinforcing the planned availability of UHTSS for 1999. I might pick up a little more ABSC tomorrow, depending upon the price. These days, if a biotech stock goes up $3.00, you can almost bet that it will be down $2-$3 the next day!

To: Richard Haugland who wrote (132)	7/17/1998 10:15:00 AM
From: Richard Haugland	Read Replies (1) \| Respond to of 359

Aurora Biosciences Announces Management Change SAN DIEGO, July 17 /PRNewswire/ -- Aurora Biosciences Corporation (Nasdaq: ABSC - news) announced today that Deborah J. Tower, vice president finance and administration, will resign from her position as of July 17 to pursue a career in business and corporate finance consulting. For the next few months, Ms. Tower will serve as a part-time consultant to Aurora focusing on financial analysis, planning and reporting, and facilities strategy. John Pashkowsky, director, finance, will handle the Company's internal financial responsibilities. biz.yahoo.com